0KCC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - OncoCyte Corp

Watchlist Manager

Watchlist

Price: 4.1 USD 0.51% Market Closed

Market Cap: $37.3B

O	OncoCyte Corp LSE:0KCC	US
M	Mhp Se OTC:MHPSY	UA
P	Pharol SGPS SA XMUN:PTCA	PT

Profitability Summary

OncoCyte Corp's profitability score is 9/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

53%

Sustainable 3Y Average Gross Margin

15%

Gross Margin is Increasing

-30% > 53%

Negative Operating Margin

-434%

Negative 3Y Average Operating Margin

-1 316%

Declining Operating Margin

1 963% > -434%

Negative Net Margin

-1 516%

Negative 3Y Average Net Margin

-3 966%

Net Margin is Increasing

-6 856% > -1 516%

Negative Free Cash Flow Margin

-613%

Negative 3Y Average Free Cash Flow Margin

-2 201%

Free Cash Flow Margin is Increasing

-5 084% > -613%

Negative ROE

-429%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-27%

Declining ROIC

18% > -36%

View All

Hide

Collapse

9 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.